[Medical treatment for osteoporosis with pulmonary disorders-from a viewpoint of an endocrinologist-.]
Today, we can treat osteoporotic patients with multiple drugs of various mechanisms and in various forms. Nevertheless, there exist few clinical evidences that exhibit an efficacy of an anti-osteoporotic drug on osteoporosis with pulmonary disorders, including asthma, COPD and OSAS. We should use drugs for osteoporotic patients with pulmonary disorders in accordance with a guideline on the management and treatment of glucocorticoid-induced osteoporosis or a guideline on the management and treatment of osteoporosis, according to whether they are treated by glucocorticoid or not.
Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Akihiro
A
Yasoda
D015519:Bone Density / Q000187:drug effects*; D000072097:Endocrinologists; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy*; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
D005938:Glucocorticoids